BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vanpouille-Box C, Hindré F. Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity. Front Oncol 2012;2:136. [PMID: 23087900 DOI: 10.3389/fonc.2012.00136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Holik HA, Ibrahim FM, Elaine AA, Putra BD, Achmad A, Kartamihardja AHS. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker. Molecules 2022;27:3062. [PMID: 35630536 DOI: 10.3390/molecules27103062] [Reference Citation Analysis]
2 Nam G, Yang Y, Kim I. Immunogenic clearance-mediated cancer vaccination. Biomaterials for Cancer Therapeutics 2020. [DOI: 10.1016/b978-0-08-102983-1.00020-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Duan X, Chan C, Lin W. Durch Nanopartikel vermittelter immunogener Zelltod ermöglicht und verstärkt die Immuntherapie gegen Krebs. Angew Chem 2019;131:680-91. [DOI: 10.1002/ange.201804882] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
4 Duan X, Chan C, Lin W. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. Angew Chem Int Ed Engl 2019;58:670-80. [PMID: 30016571 DOI: 10.1002/anie.201804882] [Cited by in Crossref: 374] [Cited by in F6Publishing: 393] [Article Influence: 74.8] [Reference Citation Analysis]
5 Cikankowitz A, Clavreul A, Tétaud C, Lemaire L, Rousseau A, Lepareur N, Dabli D, Bouchet F, Garcion E, Menei P, Couturier O, Hindré F. Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model. J Neurooncol 2017;131:49-58. [PMID: 27783195 DOI: 10.1007/s11060-016-2289-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
6 Liko F, Hindré F, Fernandez-Megia E. Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy. Biomacromolecules 2016;17:3103-14. [PMID: 27608327 DOI: 10.1021/acs.biomac.6b00929] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
7 Lepareur N, Leal E Costa L, Bocqué M, Blondelle C, Ruello C, Desjulets M, Noiret N, Cammas-Marion S. Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides. Front Med (Lausanne) 2015;2:63. [PMID: 26389121 DOI: 10.3389/fmed.2015.00063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
8 Phillips WT, Bao A, Brenner AJ, Goins BA. Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev 2014;76:39-59. [PMID: 25016083 DOI: 10.1016/j.addr.2014.07.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 6.6] [Reference Citation Analysis]
9 Demaria S, Formenti SC. Radiotherapy effects on anti-tumor immunity: implications for cancer treatment. Front Oncol 2013;3:128. [PMID: 23734344 DOI: 10.3389/fonc.2013.00128] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]